7,8,9,10-tetrahydroazepino(2,1-b)quinazolin-12(6H)-one
- CAS No.
- 4425-23-4
- Chemical Name:
- 7,8,9,10-tetrahydroazepino(2,1-b)quinazolin-12(6H)-one
- Synonyms
- RLX;PD-139530;2,3-Pentanoquinazoline-4(3H)-one;VASICINONE HCl (Deoxydihomo-'c'-);7,8,9,10-Tetrahydro-6H-azepino[2,1-b]quinazolin-12-one;6,7,8,9,10,12-Hexahydroazepino[2,1-b]quinazoline-12-one;Azepino[2,1-b]quinazolin-12(6H)-one, 7,8,9,10-tetrahydro-
- CBNumber:
- CB31339212
- Molecular Formula:
- C13H14N2O
- Molecular Weight:
- 214.26
- MDL Number:
- MFCD00661748
- MOL File:
- 4425-23-4.mol
- MSDS File:
- SDS
7,8,9,10-tetrahydroazepino(2,1-b)quinazolin-12(6H)-one price
| Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|---|
| Biosynth | EAA42523 | 6H,7H,8H,9H,10H,12H-Azepino[2,1-b]quinazolin-12-one | 4425-23-4 | 100mg | $250 | 2026-06-04 | Buy |
| Biosynth | EAA42523 | 6H,7H,8H,9H,10H,12H-Azepino[2,1-b]quinazolin-12-one | 4425-23-4 | 250mg | $325 | 2026-06-04 | Buy |
| Biosynth | EAA42523 | 6H,7H,8H,9H,10H,12H-Azepino[2,1-b]quinazolin-12-one | 4425-23-4 | 500mg | $520 | 2026-06-04 | Buy |
| Biosynth | EAA42523 | 6H,7H,8H,9H,10H,12H-Azepino[2,1-b]quinazolin-12-one | 4425-23-4 | 1000mg | $830 | 2026-06-04 | Buy |
| Biosynth | EAA42523 | 6H,7H,8H,9H,10H,12H-Azepino[2,1-b]quinazolin-12-one | 4425-23-4 | 5000mg | $2700 | 2026-06-04 | Buy |
7,8,9,10-tetrahydroazepino(2,1-b)quinazolin-12(6H)-one Chemical Properties, Uses, Production
Uses
RLX (PD 139530) is a PI3K/Akt/FoxO3a signaling inhibitor, possessing significant therapeutic potential in experimental colon cancer. RLX can effectively modulate the tumor microenvironment, enhancing the efficacy of cancer immunotherapy. RLX demonstrates the ability to improve the retention time of therapeutic agents within the tumor microenvironment by utilizing advanced nanoparticle delivery systems. RLX can be integrated with various treatment modalities, such as chemotherapy and radiotherapy, to enhance overall tumor therapy effectiveness. RLX highlights the necessity for further research into the tumor microenvironment’s dynamics to develop more tailored treatment approaches for diverse tumor types.
References
[1] The application of nanoparticles in cancer immunotherapy: Targeting tumor microenvironment
7,8,9,10-tetrahydroazepino(2,1-b)quinazolin-12(6H)-one Preparation Products And Raw materials
7,8,9,10-tetrahydroazepino(2,1-b)quinazolin-12(6H)-one Suppliers
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| TargetMol Chemicals Inc. | +1-781-999-5354; +1-00000000000 | marketing@targetmol.com | United States | 32431 | 58 |
| TargetMol Chemicals Inc. | 15002134094 | marketing@targetmol.cn | China | 29874 | 58 |
| Shanghai Amole Biotechnology Co., Ltd. | 13370042665 18916960931 | 2596183085@qq.com | China | 17234 | 58 |
| TargetMol Chemicals Inc. | 13564774135 | marketing@targetmol.com | United States | 19950 | 58 |
| Supplier | Advantage |
|---|---|
| TargetMol Chemicals Inc. | 58 |
| TargetMol Chemicals Inc. | 58 |
| Shanghai Amole Biotechnology Co., Ltd. | 58 |
| TargetMol Chemicals Inc. | 58 |
View Latest Price from 7,8,9,10-tetrahydroazepino(2,1-b)quinazolin-12(6H)-one manufacturers
4425-23-4 (7,8,9,10-tetrahydroazepino(2,1-b)quinazolin-12(6H)-one) Related Search:
1of3





